Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets open in 1 hour 55 minutes
NIKKEI 225
38,236.07
-37.98
(-0.10%)
HANG SENG
18,413.79
+206.66
(+1.14%)
CRUDE OIL
79.16
+0.21
(+0.27%)
GOLD FUTURES
2,316.40
+6.80
(+0.29%)
DOW
38,225.66
+322.37
(+0.85%)
Bitcoin GBP
47,475.74
+1,804.05
(+3.95%)
Money
Best UK mortgage deals of the week
The cheapest home loans available now
Haemonetics Corporation (HAE)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
93.33
+1.20
(+1.30%)
At close: 04:00PM EDT
93.33
0.00
(0.00%)
After hours:
04:01PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
1,270,181
1,168,660
993,196
870,463
Cost of revenue
598,290
553,563
487,694
472,625
Gross profit
671,891
615,097
505,502
397,838
Operating expenses
Research development
54,222
50,131
46,801
32,857
Selling general and administrative
407,857
376,675
340,140
275,216
Total operating expenses
491,659
459,446
434,355
340,903
Operating income or loss
180,232
155,651
71,147
56,935
Interest expense
9,118
14,630
17,121
16,834
Total other income/expenses net
-
382
9,603
32,812
Income before tax
161,077
141,403
63,629
72,913
Income tax expense
34,503
26,002
20,254
-6,556
Income from continuing operations
126,574
115,401
43,375
79,469
Net income
126,574
115,401
43,375
79,469
Net income available to common shareholders
126,574
115,401
43,375
79,469
Basic EPS
2.53
2.27
0.85
1.57
Diluted EPS
2.49
2.24
0.84
1.55
Basic average shares
50,556
50,783
51,047
50,688
Diluted average shares
51,294
51,420
51,353
51,292
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.